The glycerol lipid 77-6 stimulated IL-1β release from macrophages.
This involves activation of the inflammasome and caspase 1.
The glycerol lipid 56-5 promotes EAE disease progression.
This is independent of the inflammasome and might involve modulation of PAF signalling.
Glycerol lipids might be a starting point for development of anti-inflammatory drugs.